Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Rockwell Medical updates progress on calcitriol commercial launch, stating that the FDA has requested that the Co resubmit the application for the new contract manufacturer as a Prior Approval Supplement and pay a fee for the Agency review (6.00)As a result, <strong>the Company anticipates Calcitriol to become commercially available in the U.S. market in approximately 4-6 months</strong>. Calcitriol is Rockwell's FDA approved active Vitamin D injection for the management of hypocalcemia in patients undergoing chronic renal dialysis.</td> </tr></table>"